Brain tumor clinical trials: Pitfalls and promise for the future Mark R. Gilbert Invited Commentary Pages: 473 - 475
Recent advances in reconstructive surgery for soft-tissue sarcomas David W. ChangGeoffrey L. Robb OriginalPaper Pages: 495 - 501
Adjuvant chemotherapy for extremity soft-tissue sarcomas in adults Piero Picci OriginalPaper Pages: 502 - 507
Differentiating agents in pediatric malignancies: Retinoids in neuroblastoma C. Patrick Reynolds OriginalPaper Pages: 511 - 518
Differentiating agents in pediatric malignancies: All-trans-retinoic acid and arsenic in acute promyelocytic leukemia Elizabeth M. CallejaRaymond P. Warrell Jr OriginalPaper Pages: 519 - 523
Therapy for acute myeloid leukemia: Intensive timing of induction chemotherapy Robert J. WellsWilliam G. WoodsRobert J. Arceci OriginalPaper Pages: 524 - 528
Therapy for childhood acute myeloid leukemia: Role of allogeneic bone marrow transplantation Esteban AbellaYaddanapudi Ravindranath OriginalPaper Pages: 529 - 538
Targeting pediatric malignancies for T cell-mediated immune responses Crystal L. MackallLee J. Helman OriginalPaper Pages: 539 - 546
Monoclonal antibody-based therapy for neuroblastoma Nai-Kong V. Cheung OriginalPaper Pages: 547 - 553
Breast cancer prevention trials Deborah J. RhodesLynn C. HartmannEdith A. Perez OriginalPaper Pages: 558 - 565
Angiogenic molecules and mechanisms in breast cancer Inmin WuMarsha A. Moses OriginalPaper Pages: 566 - 571
Integration of breast imaging into cancer management Laura J. EssermanDulcy WolvertonNola Hylton OriginalPaper Pages: 572 - 581
Novel immunologic and biologic therapies for breast cancer John C. Gutheil OriginalPaper Pages: 582 - 586
Fertility and the impact of systemic therapy on hormonal status following treatment for breast cancer Halle C. F. Moore OriginalPaper Pages: 587 - 593
Does tamoxifen improve the outcome of patients who have undergone lumpectomy and radiation for ductal carcinoma in situ? Edith A. Perez Clinical Trials Report Pages: 594 - 594